2C-T-17
Sign in to saveAlso known as 4-(sec-butylthio)-2,5-dimethoxyphenethylamine, NIMITZ, 4-sec-butylthio-2,5-dimethoxyphenethylamine, 2,5-dimethoxy-4-sec-butylthiophenethylamine, 2-{4-[(butan-2-yl)sulfanyl]-2,5-dimethoxyphenyl}ethan-1-amine, 2-[4-(butan-2-ylsulfanyl)-2,5-dimethoxyphenyl]ethan-1-amine, 2-(4-butan-2-ylsulfanyl-2,5-dimethoxyphenyl)ethanamine
2C-T-17, also known as '4-sec-butylthio-2,5-dimethoxyphenethylamine or as Nimitz', is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
~3 min read
Encyclopedic overview
16 sectionsContents
- Use and effects
- Toxicity
- Interactions
- Pharmacology
- Pharmacodynamics
- Chemistry
- Synthesis
- History
- Society and culture
- Legal status
- Canada
- United Kingdom
- United States
- See also
- References
- External links
2C-T-17, also known as '4-sec-butylthio-2,5-dimethoxyphenethylamine or as Nimitz', is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
2C-T-17 was first described in the scientific literature by Alexander Shulgin and colleagues in 1991. Shortly after this, Shulgin described 2C-T-17 in greater detail in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).
Excerpted from Wikipedia’s “2C-T-17” article, available under the CC BY-SA 4.0 licence.